Profil
Ming-Chou Lee formerly worked at Quest Diagnostics Infectious Disease, Inc., as Director-Molecular Research & Development, ArcherDX LLC, as Senior Director-Assay Development, PrimeraDx, Inc., as Vice President-Product Development, and Exagen, Inc., as Chief Technology Officer from 2021 to 2022.
Dr. Lee received his doctorate degree from The University of Alabama.
Anciens postes connus de Ming-Chou Lee
| Sociétés | Poste | Fin |
|---|---|---|
| EXAGEN INC. | Directeur Technique/Scientifique/R&D | 31/12/2022 |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Corporate Officer/Principal | - |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Corporate Officer/Principal | - |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Corporate Officer/Principal | - |
Formation de Ming-Chou Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Commercial Services |
Exagen, Inc.
Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
















